{
  "cik": 1770121,
  "cik_padded": "0001770121",
  "entityName": "Sana Biotechnology, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-088215",
      "filed": "2026-03-03",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 938000.0,
        "cash": 71870000.0,
        "eps_diluted": -0.96,
        "free_cash_flow": -144766000.0,
        "net_income": -244166000.0,
        "operating_cash_flow": -143828000.0,
        "operating_income": -250319000.0,
        "stockholders_equity": 160884000.0,
        "total_assets": 416890000.0,
        "total_liabilities": 256006000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.5912458665871063,
        "roa_avg2y": -0.5320042269939319,
        "roa_period_end": -0.5856844731224063,
        "roe_avg2y": -1.1870351104067207,
        "roe_period_end": -1.5176524701026828
      }
    },
    {
      "accn": "0001193125-26-088215",
      "filed": "2026-03-03",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 33430000.0,
        "cash": 127566000.0,
        "eps_diluted": -1.16,
        "free_cash_flow": -256583000.0,
        "net_income": -266759000.0,
        "operating_cash_flow": -223153000.0,
        "operating_income": -272723000.0,
        "stockholders_equity": 250504000.0,
        "total_assets": 501020000.0,
        "total_liabilities": 250516000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.0000479034266918,
        "roa_avg2y": -0.5003362033312733,
        "roa_period_end": -0.5324318390483413,
        "roe_avg2y": -0.9916507128120295,
        "roe_period_end": -1.064889183406253
      }
    },
    {
      "accn": "0001193125-26-088215",
      "filed": "2026-03-03",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 20032000.0,
        "cash": 133517000.0,
        "eps_diluted": -1.46,
        "free_cash_flow": -273614000.0,
        "net_income": -283255000.0,
        "operating_cash_flow": -253582000.0,
        "operating_income": -293141000.0,
        "stockholders_equity": 287506000.0,
        "total_assets": 565299000.0,
        "total_liabilities": 277793000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9662163572238492,
        "roa_avg2y": -0.408142828016043,
        "roa_period_end": -0.5010711145783028,
        "roe_avg2y": -0.719998576550448,
        "roe_period_end": -0.9852142216162446
      }
    },
    {
      "accn": "0001193125-26-088215",
      "filed": "2026-03-03",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 20876000.0,
        "cash": 176765000.0,
        "eps_diluted": -1.43,
        "free_cash_flow": -310926000.0,
        "net_income": -269476000.0,
        "operating_cash_flow": -290050000.0,
        "operating_income": -272564000.0,
        "stockholders_equity": 499315000.0,
        "total_assets": 822720000.0,
        "total_liabilities": 323405000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.6476973453631475,
        "roa_avg2y": -0.27608449655171,
        "roa_period_end": -0.3275427849085959,
        "roe_avg2y": -0.4389514072536868,
        "roe_period_end": -0.5396913771867459
      }
    },
    {
      "accn": "0001564590-23-003798",
      "filed": "2025-03-17",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 29862000.0,
        "cash": 253029000.0,
        "eps_diluted": -2.14,
        "free_cash_flow": -280916000.0,
        "net_income": -355928000.0,
        "operating_cash_flow": -251054000.0,
        "operating_income": -356909000.0,
        "stockholders_equity": 728502000.0,
        "total_assets": 1129407000.0,
        "total_liabilities": 400905000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5503142064126111,
        "roa_avg2y": -0.3827794007967939,
        "roa_period_end": -0.3151459128551532,
        "roe_avg2y": -2.316349839579849,
        "roe_period_end": -0.4885751857922147
      }
    },
    {
      "accn": "0000950170-24-023119",
      "filed": "2024-02-29",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 23872000.0,
        "cash": 124806000.0,
        "eps_diluted": -21.92,
        "free_cash_flow": -161854000.0,
        "net_income": -285305000.0,
        "operating_cash_flow": -137982000.0,
        "operating_income": -286149000.0,
        "stockholders_equity": -421184000.0,
        "total_assets": 730296000.0,
        "total_liabilities": 298583000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.3906703583204618,
        "roe_avg2y": 1.0122116063477646
      }
    },
    {
      "accn": "0001564590-23-003798",
      "filed": "2023-03-16",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 26124000.0,
        "free_cash_flow": -111642000.0,
        "net_income": -130778000.0,
        "operating_cash_flow": -85518000.0,
        "operating_income": -141152000.0,
        "stockholders_equity": -142542000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 1.679547935529442
      }
    },
    {
      "accn": "0001564590-22-010539",
      "filed": "2022-03-16",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -13188000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-088215",
    "filed": "2026-03-03",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001770121.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001770121.json"
  },
  "ticker": "SANA"
}